Zhe Huang

800 Dongchuan Road
Shanghai, 200240, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Yiqi Wenyang decoction protects against the development of atherosclerosis by inhibiting vascular inflammation.

Yiqi Wenyang decoction protects against the development of atherosclerosis by inhibiting vascular inflammation.

Journal: Pharmaceutical biology

Published: April 20, 2025

Hepatic GPR110 contributes to sex disparity in the development of MASH through oestrogen receptor α-dependent signalling.

Hepatic GPR110 contributes to sex disparity in the development of MASH through oestrogen receptor α-dependent signalling.

Journal: Nature metabolism

Published: March 04, 2025

Astragaloside IV ameliorates atherosclerosis by targeting TAK1 to suppress endothelial cell proinflammatory activation.

Astragaloside IV ameliorates atherosclerosis by targeting TAK1 to suppress endothelial cell proinflammatory activation.

Journal: International immunopharmacology

Published: August 28, 2024

FSTL3 partially mediates the association of increased nonalcoholic fatty liver disease fibrosis risk with acute myocardial infarction in patients with type 2 diabetes mellitus.

FSTL3 partially mediates the association of increased nonalcoholic fatty liver disease fibrosis risk with acute myocardial infarction in patients with type 2 diabetes mellitus.

Journal: Cardiovascular diabetology

Published: August 22, 2023

The adiponectin-derived peptide ALY688 protects against the development of metabolic dysfunction-associated steatohepatitis.

The adiponectin-derived peptide ALY688 protects against the development of metabolic dysfunction-associated steatohepatitis.

Journal: Clinical and translational science

Published: August 11, 2023

Editorial: Metabolic associated fatty liver disease: clinical perspectives from pathogenesis to diagnosis and treatment.

Editorial: Metabolic associated fatty liver disease: clinical perspectives from pathogenesis to diagnosis and treatment.

Journal: Frontiers in endocrinology

Published: April 16, 2023

Fibrosis Risk in Nonalcoholic Fatty Liver Disease Is Related to Chronic Kidney Disease in Older Type 2 Diabetes Patients.

Fibrosis Risk in Nonalcoholic Fatty Liver Disease Is Related to Chronic Kidney Disease in Older Type 2 Diabetes Patients.

Journal: The Journal of clinical endocrinology and metabolism

Published: March 02, 2022

Increased neutrophil count Is associated with the development of chronic kidney disease in patients with diabetes.

Increased neutrophil count Is associated with the development of chronic kidney disease in patients with diabetes.

Journal: Journal of diabetes

Published: January 04, 2022

Showing 1-8 of 8

Last Updated: 09/26/2026